NCT07647575

Hypertonic Saline Inhalation for Nontuberculous Mycobacterial Lung Disease

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2025-10-03Est. Completion: 2028-04-30

Enrollment target: 262 participants

Locations

Contact

MAC Lung DiseaseTreatment Refractory MAC Lung Disease

This is a pivotal Phase 2/3, double-blind, placebo-controlled study of epetraborole + OBR (Optimized Background Regimen)…

Birmingham, United StatesCompleted Dec 18, 2024

Nontuberculous Mycobacterial Lung Disease

The incidence of nontuberculous mycobacterial lung disease (NTM-LD) is increasing worldwide and in Eastern Asia. NTM-LD …

Taipei, TaiwanEst. completion Dec 1, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.